The agreement is effective March 1, 2008 through 2010. It covers Magnevist in multiple presentations, including five, 10, 15 and 20mL single-dose vials, 50 and 100mL pharmacy bulk packages, and 10, 15 and 20mL pre-filled syringes of Magnevist. Ultravist will be available in four concentrations (150, 240, 300 and 370mgI) and in a variety of product presentations, including 500mL pharmacy bulk packages for the 300mgI and 370mgI concentrations.
Douglas Stefanelli, vice president and general manager, diagnostic imaging, Bayer HealthCare Pharmaceuticals, said: “We are pleased to continue our long-standing relationship with Amerinet and remain committed to providing its members with the high-quality, cost-effective products they need to serve their patient community.”